First Light Diagnostics Inc (FLD) is a medical device company, that develops and manufactures automated medical diagnostic products for the detection of healthcare associated infections. The company’s product includes a multipath analyzer system. Its multipath analyzer system detects resistant and sensitive staphylococcus aureus bacteria, toxins, and viruses for hospital clinical microbiology laboratories. MultiPath technology detects sources of infection, identifies pathogens, and determines antimicrobial susceptibility, bacteria, fungi, parasites, human cells, viruses, toxins, and disease biomarkers. FLD is headquartered in Bedford, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company First Light Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- First Light Diagnostics Inc Company Overview
- First Light Diagnostics Inc Company Snapshot
- First Light Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
- First Light Diagnostics Inc - Pipeline Analysis Overview
- First Light Diagnostics Inc - Key Facts
- First Light Diagnostics Inc - Major Products and Services
- First Light Diagnostics Inc Pipeline Products by Development Stage
- First Light Diagnostics Inc Pipeline Products Overview
- Multipath Assay - Hospital Acquired Infections
- Multipath Assay - Hospital Acquired Infections Product Overview
- MultiPath Carbapenem-Resistant Enterobacteriaceae Test
- MultiPath Carbapenem-Resistant Enterobacteriaceae Test Product Overview
- MultiPath Immunoreagent - UTI
- MultiPath Immunoreagent - UTI Product Overview
- MultiPath MRSA Diagnostic Test
- MultiPath MRSA Diagnostic Test Product Overview
- MultiPath UTI AST Assay
- MultiPath UTI AST Assay Product Overview
- MultiPath UTI AST Cartridge
- MultiPath UTI AST Cartridge Product Overview
- MultiPath UTI ID Cartridge
- MultiPath UTI ID Cartridge Product Overview
- MultiPath UTI ID Test
- MultiPath UTI ID Test Product Overview
- MultiPath VRE Diagnostic Test
- MultiPath VRE Diagnostic Test Product Overview
- First Light Diagnostics Inc - Key Competitors
- First Light Diagnostics Inc - Key Employees
- First Light Diagnostics Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- First Light Diagnostics Inc, Recent Developments
- Dec 08, 2023: First Light Diagnostics Receives 510(K) Clearance For SensiTox B. Anthracis Toxin Test
- Dec 05, 2023: First Light Diagnostics Receives FDA Clearance for its Rapid B. anthracis Toxin Test on the MultiPath Analyzer
- Jul 20, 2021: First Light Diagnostics receives FDA clearance for its rapid Clostridiodes difficile Test on the MultiPath Analyzer
- Jul 13, 2021: First Light Diagnostics receives 510(k) clearance for SensiTox C. difficile Toxin Test
- Oct 27, 2020: First Light Diagnostics receives additional funding from BARDA
- May 21, 2020: First Light Diagnostics posters and abstracts accepted, part of ECCMID 2020 Abstract Book
- Dec 18, 2019: First Light Diagnostics receives additional funding from the Biomedical Advanced Research and Development Authority (BARDA)
- Dec 03, 2019: First Light Diagnostics to present at New England Venture Summit
- Oct 30, 2019: First Light Diagnostics joins global initiative to combat antibiotic resistance
- Sep 25, 2019: Dr. Joanne Spadoro Joins First Light Diagnostics
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- First Light Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
- First Light Diagnostics Inc Pipeline Products by Equipment Type
- First Light Diagnostics Inc Pipeline Products by Indication
- First Light Diagnostics Inc, Key Facts
- First Light Diagnostics Inc, Major Products and Services
- First Light Diagnostics Inc Number of Pipeline Products by Development Stage
- First Light Diagnostics Inc Pipeline Products Summary by Development Stage
- Multipath Assay - Hospital Acquired Infections - Product Status
- Multipath Assay - Hospital Acquired Infections - Product Description
- MultiPath Carbapenem-Resistant Enterobacteriaceae Test - Product Status
- MultiPath Carbapenem-Resistant Enterobacteriaceae Test - Product Description
- MultiPath Immunoreagent - UTI - Product Status
- MultiPath Immunoreagent - UTI - Product Description
- MultiPath MRSA Diagnostic Test - Product Status
- MultiPath MRSA Diagnostic Test - Product Description
- MultiPath UTI AST Assay - Product Status
- MultiPath UTI AST Assay - Product Description
- MultiPath UTI AST Cartridge - Product Status
- MultiPath UTI AST Cartridge - Product Description
- MultiPath UTI ID Cartridge - Product Status
- MultiPath UTI ID Cartridge - Product Description
- MultiPath UTI ID Test - Product Status
- MultiPath UTI ID Test - Product Description
- MultiPath VRE Diagnostic Test - Product Status
- MultiPath VRE Diagnostic Test - Product Description
- First Light Diagnostics Inc, Key Employees
- Glossary
- First Light Diagnostics Inc Pipeline Products by Equipment Type
- First Light Diagnostics Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alpha Diagnostic International Inc
- True Diagnostics Inc
- Diagnostic HYBRIDS Inc
